Latterell Venture Partners (LVP) invests in early stage biotechnology, specialty pharmaceutical, and medical device companies with innovative technologies, large market opportunities, and passionate entrepreneurs. The LVP General Partners offer a unique blend of venture capital, entrepreneurial, technical, clinical and collaborative skills which enable entrepreneurs to create highly successful new start-ups. Over the past twenty years, the LVP team has built more than thirty successful biomedical companies. LVP is committed to building a portfolio of outstanding biotechnology and medical device companies which produce excellent returns while providing major new disease treatments to help patients worldwide. More information about LVP is available at

VantagePoint Capital Partners a global leader in financing and supporting transformative companies focused on energy innovation, Internet and digital media. With a best-in-class investment team of business and scientific experts, a broad network of corporate Strategic Partners, accomplished Senior Advisors, and more than $4 billion in committed capital, the Firm has the resources and talent to build important, industry-leading companies. Headquartered in Silicon Valley with offices in Beijing, VantagePoint has active investments in over 70 companies, including Identified, edo, Vook, Chacha, Solazyme, BrightSource Energy, Liquid Robotics, Scribd and WageWorks. For more information visit